Budur Kumar's most recent trade in Harmony Biosciences Holdings Inc was a trade of 18,750 Restricted Stock Units done . Disclosure was reported to the exchange on May 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harmony Biosciences Holdings | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 18,750 | 18,750 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 18,750 | 18,750 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings | Kumar Budur | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.86 per share. | 01 May 2025 | 8,869 | 9,881 | - | 29.9 | 264,828 | Common Stock |
| Harmony Biosciences Holdings | Kumar Budur | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 37,400 | 37,400 | - | - | Stock Option | |
| Harmony Biosciences Holdings | Kumar Budur | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 10,650 | 10,650 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 2,187 | 6,563 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 2,187 | 2,187 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings | Kumar Budur | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.01 per share. | 24 Jan 2025 | 1,151 | 1,036 | - | 38.0 | 43,750 | Common Stock |
| Harmony Biosciences Holdings | Kumar Budur | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings | Kumar Budur | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 75,000 | 75,000 | - | - | Stock Option | |
| Harmony Biosciences Holdings | Budur Kumar | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 42,500 | 42,500 | - | - | Stock Option | |
| Harmony Biosciences Holdings | Kumar Budur | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 8,750 | 8,750 | - | - | Restricted Stock Units |